Astrana Health (ASTH) Net Margin (2010 - 2026)

Astrana Health (ASTH) has 17 years of Net Margin data on file, last reported at 1.36% in Q1 2026.

• Quarterly Net Margin rose 36.0% year-over-year to 1.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.76% (down 80.0% YoY) and the FY2025 annual result came in at 0.62%, down 162.0% from the prior year.
• Net Margin climbed to 1.36% in Q1 2026 per ASTH's latest filing, from 0.24% in the prior quarter.
• The five-year high for Net Margin was 8.03% in Q3 2023, with the low at 3.55% in Q4 2023.
• Average Net Margin over 5 years is 2.59%, with a median of 3.7% recorded in 2023.
• The widest YoY moves for Net Margin: up 984 bps in 2022, down 2602 bps in 2022.
• Astrana Health's Net Margin stood at 0.3% in 2022, then plunged by 1083 bps to 3.55% in 2023, then jumped by 49 bps to 1.81% in 2024, then soared by 113 bps to 0.24% in 2025, then surged by 468 bps to 1.36% in 2026.
• Business Quant data shows ASTH's Net Margin at 1.36% in Q1 2026, 0.24% in Q4 2025, and 0.11% in Q3 2025.